Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1086/505606 | DOI Listing |
Medicine (Baltimore)
December 2024
Faculty of Medicine and Health Sciences, University of Bakht Alruda, Ad Duwaym, Sudan.
Gliomas are tumors arising in the central nervous system, frequently associated with Class I mutations and BRAF fusions. These mutations are adverse prognostic factors in juvenile gliomas, leading to high rates of recurrence and poor response to current treatments. The blood-brain barrier and the heterogeneity of gliomas complicate the development of a single treatment strategy for all cases.
View Article and Find Full Text PDFDermatol Res Pract
October 2024
Department of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
The dermatological manifestations of the coronavirus cause severe acute respiratory syndrome. The current study investigates the morphological and histopathological relationship between the emergence of skin lesions and the severity of COVID-19 across the course of the disease via a cross-sectional study. There were skin lesions (maculopapular rash, vesiculobullous lesions, urticarial lesions, cutaneous thromboembolic "CT," and erythema multiforme-like lesions "EM-like") in confirmed COVID-19 instances.
View Article and Find Full Text PDFEur J Haematol
October 2024
Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Although lenalidomide is an essential treatment for multiple myeloma (MM), skin rashes are a common adverse event. This retrospective study aimed to examine the association between skin rash development during lenalidomide treatment and the prognosis of relapsed/refractory MM. All patients who received lenalidomide at 10 hospitals between July 2009 and December 2015 were included in the study.
View Article and Find Full Text PDFInt J Rheumatol
September 2024
Department of Rheumatology and Immunology The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province 530021, China.
J Clin Med
September 2024
Faculty of Medicine, Institute of Rheumatology, University of Belgrade, 11000 Belgrade, Serbia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!